img

Global Chickenpox (Varicella) Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Chickenpox (Varicella) Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Chickenpox (Varicella) Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Chickenpox (Varicella) Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Kids Injection and Adults Injection are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Chickenpox (Varicella) Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Chickenpox (Varicella) Vaccine key manufacturers include Merck & Co., Sanofi Pasteur, GSK, Shanghai Institute, BCHT, Changsheng, Keygen, Green Cross and Biken, etc. Merck & Co., Sanofi Pasteur, GSK are top 3 players and held % sales share in total in 2022.
Chickenpox (Varicella) Vaccine can be divided into Monovalent Vaccine and Combination Vaccine, etc. Monovalent Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Chickenpox (Varicella) Vaccine is widely used in various fields, such as Kids Injection and Adults Injection, etc. Kids Injection provides greatest supports to the Chickenpox (Varicella) Vaccine industry development. In 2022, global % sales of Chickenpox (Varicella) Vaccine went into Kids Injection filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chickenpox (Varicella) Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck & Co.
Sanofi Pasteur
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
Segment by Type
Monovalent Vaccine
Combination Vaccine

Segment by Application


Kids Injection
Adults Injection

Segment by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Chickenpox (Varicella) Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Chickenpox (Varicella) Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Chickenpox (Varicella) Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Chickenpox (Varicella) Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Chickenpox (Varicella) Vaccine introduction, etc. Chickenpox (Varicella) Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Chickenpox (Varicella) Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Chickenpox (Varicella) Vaccine Market Overview
1.1 Chickenpox (Varicella) Vaccine Product Overview
1.2 Chickenpox (Varicella) Vaccine Market Segment by Type
1.2.1 Monovalent Vaccine
1.2.2 Combination Vaccine
1.3 Global Chickenpox (Varicella) Vaccine Market Size by Type
1.3.1 Global Chickenpox (Varicella) Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Chickenpox (Varicella) Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Chickenpox (Varicella) Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Chickenpox (Varicella) Vaccine Sales Breakdown by Type (2018-2024)
2 Global Chickenpox (Varicella) Vaccine Market Competition by Company
2.1 Global Top Players by Chickenpox (Varicella) Vaccine Sales (2018-2024)
2.2 Global Top Players by Chickenpox (Varicella) Vaccine Revenue (2018-2024)
2.3 Global Top Players by Chickenpox (Varicella) Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Chickenpox (Varicella) Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Chickenpox (Varicella) Vaccine Market Competitive Situation and Trends
2.5.1 Chickenpox (Varicella) Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Chickenpox (Varicella) Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chickenpox (Varicella) Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Chickenpox (Varicella) Vaccine Market
2.8 Key Manufacturers Chickenpox (Varicella) Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Chickenpox (Varicella) Vaccine Status and Outlook by Region
3.1 Global Chickenpox (Varicella) Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Chickenpox (Varicella) Vaccine Historic Market Size by Region
3.2.1 Global Chickenpox (Varicella) Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Chickenpox (Varicella) Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Chickenpox (Varicella) Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Chickenpox (Varicella) Vaccine Forecasted Market Size by Region
3.3.1 Global Chickenpox (Varicella) Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Chickenpox (Varicella) Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Chickenpox (Varicella) Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Chickenpox (Varicella) Vaccine by Application
4.1 Chickenpox (Varicella) Vaccine Market Segment by Application
4.1.1 Kids Injection
4.1.2 Adults Injection
4.2 Global Chickenpox (Varicella) Vaccine Market Size by Application
4.2.1 Global Chickenpox (Varicella) Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global Chickenpox (Varicella) Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Chickenpox (Varicella) Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Chickenpox (Varicella) Vaccine Sales Breakdown by Application (2018-2024)
5 North America Chickenpox (Varicella) Vaccine by Country
5.1 North America Chickenpox (Varicella) Vaccine Historic Market Size by Country
5.1.1 North America Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Chickenpox (Varicella) Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Chickenpox (Varicella) Vaccine Sales in Value by Country (2018-2024)
5.2 North America Chickenpox (Varicella) Vaccine Forecasted Market Size by Country
5.2.1 North America Chickenpox (Varicella) Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Chickenpox (Varicella) Vaccine Sales in Value by Country (2024-2034)
6 Europe Chickenpox (Varicella) Vaccine by Country
6.1 Europe Chickenpox (Varicella) Vaccine Historic Market Size by Country
6.1.1 Europe Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Chickenpox (Varicella) Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Chickenpox (Varicella) Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Chickenpox (Varicella) Vaccine Forecasted Market Size by Country
6.2.1 Europe Chickenpox (Varicella) Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Chickenpox (Varicella) Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Chickenpox (Varicella) Vaccine by Region
7.1 Asia-Pacific Chickenpox (Varicella) Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Chickenpox (Varicella) Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Chickenpox (Varicella) Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Chickenpox (Varicella) Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Chickenpox (Varicella) Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Chickenpox (Varicella) Vaccine Sales in Value by Region (2024-2034)
8 Latin America Chickenpox (Varicella) Vaccine by Country
8.1 Latin America Chickenpox (Varicella) Vaccine Historic Market Size by Country
8.1.1 Latin America Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Chickenpox (Varicella) Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Chickenpox (Varicella) Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Chickenpox (Varicella) Vaccine Forecasted Market Size by Country
8.2.1 Latin America Chickenpox (Varicella) Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Chickenpox (Varicella) Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Chickenpox (Varicella) Vaccine by Country
9.1 Middle East and Africa Chickenpox (Varicella) Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Chickenpox (Varicella) Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Chickenpox (Varicella) Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Chickenpox (Varicella) Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Chickenpox (Varicella) Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Chickenpox (Varicella) Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Chickenpox (Varicella) Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck & Co.
10.1.1 Merck & Co. Company Information
10.1.2 Merck & Co. Introduction and Business Overview
10.1.3 Merck & Co. Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck & Co. Chickenpox (Varicella) Vaccine Products Offered
10.1.5 Merck & Co. Recent Development
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur Company Information
10.2.2 Sanofi Pasteur Introduction and Business Overview
10.2.3 Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sanofi Pasteur Chickenpox (Varicella) Vaccine Products Offered
10.2.5 Sanofi Pasteur Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GSK Chickenpox (Varicella) Vaccine Products Offered
10.3.5 GSK Recent Development
10.4 Shanghai Institute
10.4.1 Shanghai Institute Company Information
10.4.2 Shanghai Institute Introduction and Business Overview
10.4.3 Shanghai Institute Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Shanghai Institute Chickenpox (Varicella) Vaccine Products Offered
10.4.5 Shanghai Institute Recent Development
10.5 BCHT
10.5.1 BCHT Company Information
10.5.2 BCHT Introduction and Business Overview
10.5.3 BCHT Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 BCHT Chickenpox (Varicella) Vaccine Products Offered
10.5.5 BCHT Recent Development
10.6 Changsheng
10.6.1 Changsheng Company Information
10.6.2 Changsheng Introduction and Business Overview
10.6.3 Changsheng Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Changsheng Chickenpox (Varicella) Vaccine Products Offered
10.6.5 Changsheng Recent Development
10.7 Keygen
10.7.1 Keygen Company Information
10.7.2 Keygen Introduction and Business Overview
10.7.3 Keygen Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Keygen Chickenpox (Varicella) Vaccine Products Offered
10.7.5 Keygen Recent Development
10.8 Green Cross
10.8.1 Green Cross Company Information
10.8.2 Green Cross Introduction and Business Overview
10.8.3 Green Cross Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Green Cross Chickenpox (Varicella) Vaccine Products Offered
10.8.5 Green Cross Recent Development
10.9 Biken
10.9.1 Biken Company Information
10.9.2 Biken Introduction and Business Overview
10.9.3 Biken Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Biken Chickenpox (Varicella) Vaccine Products Offered
10.9.5 Biken Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Chickenpox (Varicella) Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Chickenpox (Varicella) Vaccine Industrial Chain Analysis
11.4 Chickenpox (Varicella) Vaccine Market Dynamics
11.4.1 Chickenpox (Varicella) Vaccine Industry Trends
11.4.2 Chickenpox (Varicella) Vaccine Market Drivers
11.4.3 Chickenpox (Varicella) Vaccine Market Challenges
11.4.4 Chickenpox (Varicella) Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Chickenpox (Varicella) Vaccine Distributors
12.3 Chickenpox (Varicella) Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Monovalent Vaccine
Table 2. Major Company of Combination Vaccine
Table 3. Global Chickenpox (Varicella) Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Chickenpox (Varicella) Vaccine Sales by Type (2018-2024) & (K Doses)
Table 5. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Chickenpox (Varicella) Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Chickenpox (Varicella) Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Chickenpox (Varicella) Vaccine Price by Type (2018-2024) & (USD/dose)
Table 9. Global Chickenpox (Varicella) Vaccine Sales by Type (2024-2034) & (K Doses)
Table 10. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Chickenpox (Varicella) Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Chickenpox (Varicella) Vaccine Price by Type (2024-2034) & (USD/dose)
Table 14. North America Chickenpox (Varicella) Vaccine Sales by Type (2018-2024) & (K Doses)
Table 15. North America Chickenpox (Varicella) Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2018-2024)
Table 17. Europe Chickenpox (Varicella) Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2018-2024)
Table 19. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2018-2024)
Table 21. Latin America Chickenpox (Varicella) Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2018-2024)
Table 23. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Chickenpox (Varicella) Vaccine Sales by Company (2018-2024) & (K Doses)
Table 25. Global Chickenpox (Varicella) Vaccine Sales Share by Company (2018-2024)
Table 26. Global Chickenpox (Varicella) Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Chickenpox (Varicella) Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Chickenpox (Varicella) Vaccine Price by Company (2018-2024) & (USD/dose)
Table 29. Global Chickenpox (Varicella) Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Chickenpox (Varicella) Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chickenpox (Varicella) Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Chickenpox (Varicella) Vaccine Market
Table 33. Key Manufacturers Chickenpox (Varicella) Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Chickenpox (Varicella) Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Chickenpox (Varicella) Vaccine Sales by Region (2018-2024) & (K Doses)
Table 37. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Chickenpox (Varicella) Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2018-2024)
Table 41. Global Chickenpox (Varicella) Vaccine Sales by Region (2024-2034) & (K Doses)
Table 42. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Chickenpox (Varicella) Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2024-2034)
Table 46. Global Chickenpox (Varicella) Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Chickenpox (Varicella) Vaccine Sales by Application (2018-2024) & (K Doses)
Table 48. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Chickenpox (Varicella) Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global Chickenpox (Varicella) Vaccine Price by Application (2018-2024) & (USD/dose)
Table 52. Global Chickenpox (Varicella) Vaccine Sales by Application (2024-2034) & (K Doses)
Table 53. Global Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Chickenpox (Varicella) Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application (2024-2034)
Table 56. Global Chickenpox (Varicella) Vaccine Price by Application (2024-2034) & (USD/dose)
Table 57. North America Chickenpox (Varicella) Vaccine Sales by Application (2018-2024) (K Doses)
Table 58. North America Chickenpox (Varicella) Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Chickenpox (Varicella) Vaccine Sales by Application (2018-2024) (K Doses)
Table 60. Europe Chickenpox (Varicella) Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Application (2018-2024) (K Doses)
Table 62. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Chickenpox (Varicella) Vaccine Sales by Application (2018-2024) (K Doses)
Table 64. Latin America Chickenpox (Varicella) Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Application (2018-2024) (K Doses)
Table 66. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Chickenpox (Varicella) Vaccine Sales by Country (2018-2024) & (K Doses)
Table 68. North America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Chickenpox (Varicella) Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Chickenpox (Varicella) Vaccine Sales by Country (2024-2034) & (K Doses)
Table 72. North America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Chickenpox (Varicella) Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Chickenpox (Varicella) Vaccine Sales by Country (2018-2024) & (K Doses)
Table 76. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Chickenpox (Varicella) Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Chickenpox (Varicella) Vaccine Sales by Country (2024-2034) & (K Doses)
Table 80. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Chickenpox (Varicella) Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Region (2018-2024) & (K Doses)
Table 84. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Region (2024-2034) & (K Doses)
Table 88. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Chickenpox (Varicella) Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Chickenpox (Varicella) Vaccine Sales by Country (2018-2024) & (K Doses)
Table 92. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Chickenpox (Varicella) Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Chickenpox (Varicella) Vaccine Sales by Country (2024-2034) & (K Doses)
Table 96. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Chickenpox (Varicella) Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2018-2024) & (K Doses)
Table 100. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2024-2034) & (K Doses)
Table 104. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Value by Country (2024-2034)
Table 107. Merck & Co. Company Information
Table 108. Merck & Co. Introduction and Business Overview
Table 109. Merck & Co. Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2024)
Table 110. Merck & Co. Chickenpox (Varicella) Vaccine Product
Table 111. Merck & Co. Recent Development
Table 112. Sanofi Pasteur Company Information
Table 113. Sanofi Pasteur Introduction and Business Overview
Table 114. Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2024)
Table 115. Sanofi Pasteur Chickenpox (Varicella) Vaccine Product
Table 116. Sanofi Pasteur Recent Development
Table 117. GSK Company Information
Table 118. GSK Introduction and Business Overview
Table 119. GSK Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2024)
Table 120. GSK Chickenpox (Varicella) Vaccine Product
Table 121. GSK Recent Development
Table 122. Shanghai Institute Company Information
Table 123. Shanghai Institute Introduction and Business Overview
Table 124. Shanghai Institute Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2024)
Table 125. Shanghai Institute Chickenpox (Varicella) Vaccine Product
Table 126. Shanghai Institute Recent Development
Table 127. BCHT Company Information
Table 128. BCHT Introduction and Business Overview
Table 129. BCHT Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2024)
Table 130. BCHT Chickenpox (Varicella) Vaccine Product
Table 131. BCHT Recent Development
Table 132. Changsheng Company Information
Table 133. Changsheng Introduction and Business Overview
Table 134. Changsheng Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2024)
Table 135. Changsheng Chickenpox (Varicella) Vaccine Product
Table 136. Changsheng Recent Development
Table 137. Keygen Company Information
Table 138. Keygen Introduction and Business Overview
Table 139. Keygen Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2024)
Table 140. Keygen Chickenpox (Varicella) Vaccine Product
Table 141. Keygen Recent Development
Table 142. Green Cross Company Information
Table 143. Green Cross Introduction and Business Overview
Table 144. Green Cross Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2024)
Table 145. Green Cross Chickenpox (Varicella) Vaccine Product
Table 146. Green Cross Recent Development
Table 147. Biken Company Information
Table 148. Biken Introduction and Business Overview
Table 149. Biken Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/dose) and Gross Margin (2018-2024)
Table 150. Biken Chickenpox (Varicella) Vaccine Product
Table 151. Biken Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Chickenpox (Varicella) Vaccine Market Trends
Table 155. Chickenpox (Varicella) Vaccine Market Drivers
Table 156. Chickenpox (Varicella) Vaccine Market Challenges
Table 157. Chickenpox (Varicella) Vaccine Market Restraints
Table 158. Chickenpox (Varicella) Vaccine Distributors List
Table 159. Chickenpox (Varicella) Vaccine Downstream Customers
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Chickenpox (Varicella) Vaccine Product Picture
Figure 2. Global Chickenpox (Varicella) Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Chickenpox (Varicella) Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Chickenpox (Varicella) Vaccine Sales Status and Outlook (2018-2034) & (K Doses)
Figure 5. Product Picture of Monovalent Vaccine
Figure 6. Global Monovalent Vaccine Sales YoY Growth (2018-2034) & (K Doses)
Figure 7. Product Picture of Combination Vaccine
Figure 8. Global Combination Vaccine Sales YoY Growth (2018-2034) & (K Doses)
Figure 9. Global Chickenpox (Varicella) Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Chickenpox (Varicella) Vaccine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Chickenpox (Varicella) Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Chickenpox (Varicella) Vaccine Revenue in 2022
Figure 23. Chickenpox (Varicella) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Kids Injection
Figure 25. Global Kids Injection Sales YoY Growth (2018-2034) & (K Doses)
Figure 26. Product Picture of Adults Injection
Figure 27. Global Adults Injection Sales YoY Growth (2018-2034) & (K Doses)
Figure 28. Global Chickenpox (Varicella) Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 29. Global Chickenpox (Varicella) Vaccine Sales Market Share by Application in 2022 & 2034
Figure 30. North America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application in 2022
Figure 31. North America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application in 2022
Figure 32. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. Europe Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Chickenpox (Varicella) Vaccine Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Chickenpox (Varicella) Vaccine Manufacturing Cost Structure
Figure 41. Chickenpox (Varicella) Vaccine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed